Diabetes, Vol 35, Issue 11 1249-1253, Copyright © 1986 by American Diabetes Association

ARTICLES

Leucine metabolism in type II diabetes mellitus

MA Staten, DE Matthews and DM Bier

Severe muscle wasting is a well-recognized characteristic of untreated insulin-deficient diabetes mellitus, a condition in which leucine turnover and oxidation are accelerated. To ascertain whether a similar circumstance exists in type II diabetes when insulin is present but with reduced efficacy, we investigated leucine turnover and oxidation in five obese type II diabetic women by tracer infusion of L-[1-13C,15N]leucine in the postabsorptive state both before and after intensive insulin therapy. With conventional treatment, the type II diabetic women received 61 +/- 33 (SD) U/day of insulin, and their fasting plasma glucose averaged 194 +/- 41 (SD) mg/dl. Leucine carbon flux (QC), nitrogen flux (QN), and oxidation (C) averaged 6.4 +/- 1.2, 15.6 +/- 4.6, and 1.4 +/- 0.3 mmol/h, respectively. These values were not different from the respective values of 6.6 +/- 1.3, 17.0 +/- 8.3, and 1.0 +/- 0.2 mmol/h in matched obese nondiabetic controls, suggesting that leucine metabolism is not altered in insulin-treated type II diabetics. After a week of intensive insulin therapy in which the same diabetic subjects received 94 +/- 36 U/day of insulin, postabsorptive plasma glucose declined to 117 +/- 26 mg/dl. Leucine QC (6.2 +/- 1.0), QN (14.8 +/- 3.7), and C (1.5 +/- 0.5 mmol/h) were unaltered by the increased insulin therapy. Thus, obese type II diabetics had normal leucine kinetics but were hyperglycemic while receiving conventional insulin therapy. Additional intensive insulin therapy in these diabetic subjects improved plasma glucose but did not alter leucine kinetics.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. Moller and K. S. Nair Diabetes and Protein Metabolism Diabetes, January 1, 2008; 57(1): 3 - 4. [Full Text] [PDF]

				S. Pereira, E. B. Marliss, J. A. Morais, S. Chevalier, and R. Gougeon Insulin Resistance of Protein Metabolism in Type 2 Diabetes Diabetes, January 1, 2008; 57(1): 56 - 63. [Abstract] [Full Text] [PDF]

				D. N. Reeds, W. T. Cade, B. W. Patterson, W. G. Powderly, S. Klein, and K. E. Yarasheski Whole-Body Proteolysis Rate Is Elevated in HIV-Associated Insulin Resistance. Diabetes, October 1, 2006; 55(10): 2849 - 2855. [Abstract] [Full Text] [PDF]

				J. A. Bell, E. Volpi, S. Fujita, J. G. Cadenas, M. Sheffield-Moore, and B. B. Rasmussen Skeletal Muscle Protein Anabolic Response to Increased Energy and Insulin Is Preserved in Poorly Controlled Type 2 Diabetes J. Nutr., May 1, 2006; 136(5): 1249 - 1255. [Abstract] [Full Text] [PDF]

				P. Tessari, A. Coracina, E. Kiwanuka, M. Vedovato, M. Vettore, A. Valerio, M. Zaramella, and G. Garibotto Effects of Insulin on Methionine and Homocysteine Kinetics in Type 2 Diabetes With Nephropathy Diabetes, October 1, 2005; 54(10): 2968 - 2976. [Abstract] [Full Text] [PDF]

				G. Lattuada, L. P. Sereni, D. Ruggieri, A. Scollo, S. Benedini, F. Ragogna, F. Costantino, A. Battezzati, L. Luzi, and G. Perseghin Postabsorptive and Insulin-Stimulated Energy Homeostasis and Leucine Turnover in Offspring of Type 2 Diabetic Patients Diabetes Care, November 1, 2004; 27(11): 2716 - 2722. [Abstract] [Full Text] [PDF]

				M. J. Hamadeh and L. J. Hoffer Effect of protein restriction on sulfur amino acid catabolism in insulin-dependent diabetes mellitus Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E382 - E389. [Abstract] [Full Text] [PDF]

				P. Halvatsiotis, K. R. Short, M. Bigelow, and K. S. Nair Synthesis Rate of Muscle Proteins, Muscle Functions, and Amino Acid Kinetics in Type 2 Diabetes Diabetes, August 1, 2002; 51(8): 2395 - 2404. [Abstract] [Full Text] [PDF]

				P. Lucidi, N. Parlanti, F. Piccioni, F. Santeusanio, and P. de Feo Short-Term Treatment with Low Doses of Recombinant Human GH Stimulates Lipolysis in Visceral Obese Men J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3105 - 3109. [Abstract] [Full Text] [PDF]

				A. P. Richardson and J. A. Tayek Type 2 diabetic patients may have a mild form of an injury response: a clinical research center study Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1286 - E1290. [Abstract] [Full Text] [PDF]

				C. Castaneda, O. I Bermudez, and K. L Tucker Protein nutritional status and function are associated with type 2 diabetes in Hispanic elders Am. J. Clinical Nutrition, July 1, 2000; 72(1): 89 - 95. [Abstract] [Full Text] [PDF]

				D. Adey, R. Kumar, J. T. McCarthy, and K. S. Nair Reduced synthesis of muscle proteins in chronic renal failure Am J Physiol Endocrinol Metab, February 1, 2000; 278(2): E219 - E225. [Abstract] [Full Text] [PDF]

				P. De Feo Fed State Protein Metabolism in Diabetes Mellitus J. Nutr., February 1, 1998; 128(2): 328 - 328. [Abstract] [Full Text]

				P. Balagopal, S. Sweeten, and N. Mauras Increased synthesis rate of fibrinogen as a basis for its elevated plasma levels in obese female adolescents Am J Physiol Endocrinol Metab, April 1, 2002; 282(4): E899 - E904. [Abstract] [Full Text] [PDF]